HPGD and malignant colon neoplasm: 15-PGDH is highly expressed in normal colon epithelium, but its expression is strongly decreased in colon cancers [20]; therefore, agents that both enhance 15-PGDH expression and suppress COX-2 production may more effectively prevent CAC, as exemplified by the achievements with a synthetic triterpenoid or NSAIDs.